These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7654491)

  • 1. Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
    Br J Clin Pharmacol; 1995 Jun; 39(6):692-5. PubMed ID: 7654491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.
    Abernethy DR; Greenblatt DJ; Ameer B; Shader RI
    J Pharmacol Exp Ther; 1985 Aug; 234(2):345-9. PubMed ID: 4020675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frusemide and its acyl glucuronide show a short and long phase in elimination kinetics and pharmacodynamic effect in man.
    Vree TB; Van Den Biggelaar-Martea M; Verwey-Van Wissen CP
    J Pharm Pharmacol; 1995 Nov; 47(11):964-9. PubMed ID: 8708993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of urinary pH on the pharmacokinetics of salicylic acid, with its glycine and glucuronide conjugates in human.
    Vree TB; Van Ewijk-Beneken Kolmer EW; Verwey-Van Wissen CP; Hekster YA
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):550-8. PubMed ID: 7834163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment.
    Vree TB; Van den Biggelaar-Martea M; Van Ewijk-Beneken Kolmer EW; Hekster YA
    Pharm World Sci; 1993 Aug; 15(4):165-70. PubMed ID: 8220301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic clearance of furosemide in the rat.
    Wallin JD; Ryals P; Kaplowitz N
    J Pharmacol Exp Ther; 1977 Jan; 200(1):52-7. PubMed ID: 833762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.
    Macdonald JI; Wallace SM; Herman RJ; Verbeeck RK
    Eur J Clin Pharmacol; 1995; 47(6):519-23. PubMed ID: 7768255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac.
    Smith PC; Langendijk PN; Bosso JA; Benet LZ
    Clin Pharmacol Ther; 1985 Aug; 38(2):121-7. PubMed ID: 3874742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic actions of enalapril in humans: effect of probenecid pretreatment.
    Noormohamed FH; McNabb WR; Lant AF
    J Pharmacol Exp Ther; 1990 Apr; 253(1):362-8. PubMed ID: 2158548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
    Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
    Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of furosemide with its acyl glucuronide in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis with fluorescence detection. Preliminary pharmacokinetics and effect of probenecid.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
    J Chromatogr B Biomed Appl; 1994 Apr; 655(1):53-62. PubMed ID: 8061834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-gradient high-performance liquid chromatographic analysis and preliminary pharmacokinetics of flumequine and flumequine acyl glucuronide in humans: effect of probenecid.
    Vree TB; van Ewijk-Beneken Kolmer EW; Nouws JF
    J Chromatogr; 1992 Aug; 579(1):131-41. PubMed ID: 1447340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of co-administered organic acids on the kinetics and dynamics of frusemide.
    Sommers DK; Meyer EC; Moncrieff J
    Br J Clin Pharmacol; 1991 Oct; 32(4):489-93. PubMed ID: 1958444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle.
    Sallustio BC; Purdie YJ; Birkett DJ; Meffin PJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):288-94. PubMed ID: 2795462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A renal mechanism for the clofibric acid-probenecid interaction.
    Meffin PJ; Zilm DM; Veenendaal JR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):739-42. PubMed ID: 6655567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
    Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
    Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.
    Liu S; Beringer PM; Hidayat L; Rao AP; Louie S; Burckart GJ; Shapiro B
    J Clin Pharmacol; 2008 Aug; 48(8):957-65. PubMed ID: 18511651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probenecid on the enantioselective pharmacokinetics of oxprenolol and its glucuronides in the rabbit.
    Laethem ME; Belpaire FM; Wijnant P; Bogaert MG
    Pharm Res; 1995 Dec; 12(12):1964-7. PubMed ID: 8786974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid.
    Pichette V; du Souich P
    J Am Soc Nephrol; 1996 Feb; 7(2):345-9. PubMed ID: 8785407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.